advertisement

Topcon

Zeng L 21

Showing records 1 to 21 | Display all abstracts from Zeng L

108376 Outcomes of Partial Versus Complete Goniotomy With or Without Phacoemulsification for Primary Open Angle Glaucoma: A Multicenter Study
Song Y
Journal of Glaucoma 2023; 32: 563-568
108386 Rapamycin suppresses neuroinflammation and protects retinal ganglion cell loss after optic nerve crush
Wang F
International immunopharmacology 2023; 119: 110171
107646 Integrated aqueous humor ceRNA and miRNA-TF-mRNA network analysis reveals potential molecular mechanisms governing primary open-angle glaucoma pathogenesis
Wang X
Indian Journal of Ophthalmology 2023; 71: 553-559
108376 Outcomes of Partial Versus Complete Goniotomy With or Without Phacoemulsification for Primary Open Angle Glaucoma: A Multicenter Study
Zhu X
Journal of Glaucoma 2023; 32: 563-568
107646 Integrated aqueous humor ceRNA and miRNA-TF-mRNA network analysis reveals potential molecular mechanisms governing primary open-angle glaucoma pathogenesis
Chen M
Indian Journal of Ophthalmology 2023; 71: 553-559
108386 Rapamycin suppresses neuroinflammation and protects retinal ganglion cell loss after optic nerve crush
Song Y
International immunopharmacology 2023; 119: 110171
107646 Integrated aqueous humor ceRNA and miRNA-TF-mRNA network analysis reveals potential molecular mechanisms governing primary open-angle glaucoma pathogenesis
Liu L
Indian Journal of Ophthalmology 2023; 71: 553-559
108386 Rapamycin suppresses neuroinflammation and protects retinal ganglion cell loss after optic nerve crush
Liu P
International immunopharmacology 2023; 119: 110171
107646 Integrated aqueous humor ceRNA and miRNA-TF-mRNA network analysis reveals potential molecular mechanisms governing primary open-angle glaucoma pathogenesis
Zeng L
Indian Journal of Ophthalmology 2023; 71: 553-559
108386 Rapamycin suppresses neuroinflammation and protects retinal ganglion cell loss after optic nerve crush
Ma F
International immunopharmacology 2023; 119: 110171
108376 Outcomes of Partial Versus Complete Goniotomy With or Without Phacoemulsification for Primary Open Angle Glaucoma: A Multicenter Study
Shu J
Journal of Glaucoma 2023; 32: 563-568
108386 Rapamycin suppresses neuroinflammation and protects retinal ganglion cell loss after optic nerve crush
Peng Z
International immunopharmacology 2023; 119: 110171
108376 Outcomes of Partial Versus Complete Goniotomy With or Without Phacoemulsification for Primary Open Angle Glaucoma: A Multicenter Study
Dang G; Zhou W
Journal of Glaucoma 2023; 32: 563-568
108386 Rapamycin suppresses neuroinflammation and protects retinal ganglion cell loss after optic nerve crush
Pang Y
International immunopharmacology 2023; 119: 110171
108376 Outcomes of Partial Versus Complete Goniotomy With or Without Phacoemulsification for Primary Open Angle Glaucoma: A Multicenter Study
Sun L
Journal of Glaucoma 2023; 32: 563-568
108386 Rapamycin suppresses neuroinflammation and protects retinal ganglion cell loss after optic nerve crush
Hu H; Zeng L
International immunopharmacology 2023; 119: 110171
108376 Outcomes of Partial Versus Complete Goniotomy With or Without Phacoemulsification for Primary Open Angle Glaucoma: A Multicenter Study
Li F
Journal of Glaucoma 2023; 32: 563-568
108386 Rapamycin suppresses neuroinflammation and protects retinal ganglion cell loss after optic nerve crush
Luo H
International immunopharmacology 2023; 119: 110171
108376 Outcomes of Partial Versus Complete Goniotomy With or Without Phacoemulsification for Primary Open Angle Glaucoma: A Multicenter Study
Lin F
Journal of Glaucoma 2023; 32: 563-568
108386 Rapamycin suppresses neuroinflammation and protects retinal ganglion cell loss after optic nerve crush
Zhang X
International immunopharmacology 2023; 119: 110171
108376 Outcomes of Partial Versus Complete Goniotomy With or Without Phacoemulsification for Primary Open Angle Glaucoma: A Multicenter Study
Liang X; Wang Z; Zhang Y; Chen W; Zeng L; Tang L; Xie L; Lam DSC; Wang N; Barton K; Weinreb RN; Zhang X;
Journal of Glaucoma 2023; 32: 563-568

Issue 23-4

Change Issue


advertisement

Oculus